Cargando…

Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy

INTRODUCTION: Today, a new paradigm has emerged for cancer treatment introducing combination therapies. Doxil, a liposomal doxorubicin serving as a chemotherapeutic agent, is an effective immunogenic killer of cancer cells. Anti-CTLA-4 has been approved for the treatment of some cancers, including m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alimohammadi, Reza, Alibeigi, Razieh, Nikpoor, Amin Reza, Chalbatani, Ghanbar Mahmoodi, Webster, Thomas J, Jaafari, Mahmoud Reza, Jalali, Seyed Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394514/ https://www.ncbi.nlm.nih.gov/pubmed/32801691 http://dx.doi.org/10.2147/IJN.S260760

Ejemplares similares

Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model
por: Alimohammadi, Reza, et al.
Publicado: (2023)

Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments
por: Rostami, Elham, et al.
Publicado: (2022)

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2020)

CAR-T cells: Early successes in blood cancer and challenges in solid tumors
por: Dana, Hassan, et al.
Publicado: (2021)

Enhanced immune response induced by P5 HER2/neu‐derived peptide‐pulsed dendritic cells as a preventive cancer vaccine
por: Gholizadeh, Zahra, et al.
Publicado: (2017)

The Role and Function of Ras-association domain family in Cancer: A Review
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment
por: Dana, Hassan, et al.
Publicado: (2020)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells
por: Saremi, Sara Shokooh, et al.
Publicado: (2018)

Multimodality Imaging of Tumor Response to Doxil
por: Zhang, Fan, et al.
Publicado: (2011)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
por: Soltantoyeh, Tahereh, et al.
Publicado: (2021)

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
por: Yazdani, Mona, et al.
Publicado: (2021)

Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil
por: Banciu, Manuela, et al.
Publicado: (2008)

Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity
por: Helke, Kristi L., et al.
Publicado: (2022)

Does Long-Term Administration of a Beta-Blocker (Timolol) Induce Fibril-Based Cataract Formation In-vivo?
por: Nikbakht, Mohammad Reza, et al.
Publicado: (2014)

CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
por: Soleimani, Anvar, et al.
Publicado: (2022)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
por: Neun, Barry W., et al.
Publicado: (2018)

A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs
por: Tran, Anh M., et al.
Publicado: (2020)

Optimization of post-insertion method to conjugate Doxil with anti-CD133 monoclonal antibodies: Investigating the specific binding and cytotoxicity to colorectal cancer cells in vitro
por: Dadashi Noshahr, Karim, et al.
Publicado: (2020)

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
por: Rios-Doria, Jonathan, et al.
Publicado: (2015)

Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance
por: Wei, Xiaohui, et al.
Publicado: (2018)

The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2023)

Integrative and in-vitro analysis reveal hsa_circ_001787 can act as a diagnostic biomarker for colorectal cancer
por: Chalbatani, Ghanbar Mahmoodi, et al.
Publicado: (2021)

Combination of CTLA-4 and PD-1 blockers for treatment of cancer
por: Rotte, Anand
Publicado: (2019)

Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
por: You, Shaojin, et al.
Publicado: (2010)

Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil)
por: Tsukioka, Yoshihisa, et al.
Publicado: (2002)

Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil(Ⓡ)
por: Zhang, Ruoshi, et al.
Publicado: (2020)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2019)

Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats
por: ten Hagen, T L M, et al.
Publicado: (2004)

Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells
por: Wu, Xian, et al.
Publicado: (2018)

The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)

The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial
por: Hassaniazad, Mehdi, et al.
Publicado: (2020)

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
por: Gerdes, Lisa Ann, et al.
Publicado: (2016)

Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
por: Nordström, Rickard, et al.
Publicado: (2021)

Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015)

Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)

Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
por: Razazan, Atefeh, et al.
Publicado: (2017)

Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil(®)) to Tumour Cells Using a Novel TIMP3 Peptide
por: Aldughaim, Mohammed S., et al.
Publicado: (2020)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ae7po2pein720b14jqsghgt9h4